2006～2016年恩施州新生儿疾病筛查情况分析

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (33 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To analyze the screening status,incidence and recall rate of congenital hypothyroidism(CH)and phenylketonuria (PKU)in Enshi Prefecture since the application of neonatal disease screening.Methods A retrospective analysis of neonatal disease screening data from 2006 to 2016 in Enshi Prefecture was conducted.Thyroid hormone(TSH)and Phenylalanine(PA)concentrations were measured by time-resolved immunofluorescence and immunofluorescence,respectively.Results From 2006 to 2016,a total of 290 973 neonates were screened by the Neonatal Disease Screening Center of Enshi Prefecture.The average positive detection rate of CH was 1∶2575,and the average positive detection rate of PKU was 1∶41 568.From 2006 to 2016,the number of screenings arose from 4508 to 33 271,and the screening rate increased from 15.82%to 94.43%.The positive rate of CH increased from 0 to 1∶2218.The positive rate of PKU increased from 0 to 1∶41 568.The screening rate and positive rate increased significantly over the ten years.The average recall rate of CH and PKU from 2006 to 2016 was 79.7%and 76.5%,respectively.The tendency of recall rate change was irregular.Conclusion The screening of newborn diseases in Enshi Prefecture is on the right track.In order to reduce the incidence of neonatal growth and metal development disorder,the management of neonatal disease screening should be strengthened.Also,early detection,diagnosis and treatment should be ensured.

Key words： Neonate Hypothyroidism Phenylketonuria Screening Enshi Prefecture

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	XIE Ying
	WANG Yong
	XIANG Shi-gui
	TIAN Fang-fang

Cite this article:

XIE Ying,WANG Yong,XIANG Shi-gui, et al. Analysis of neonatal disease screening in Enshi from 2006 to 2016[J]. 中国当代医药, 2019, 26(16): 199-201.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2019/V26/I16/199

[3]	顾学范，叶军.新生儿疾病筛查[M].上海：上海科学技术文献出版社，2003：260-265.
[4]	吴红波，吕魏峰，王云霞.莱芜市133 866例新生儿疾病筛查结果分析[J].中国儿童保健杂志，2013，21（4）：442-443，448.
[5]	赖婷，李小洪，邓奎，朱军.2006～2016年中国新生儿疾病筛查覆盖率分析[J].中国妇幼保健，2018，33（16）：3601-3604.
	[6王荣贵，陈萍，金爱枝.2005-2015年荆州市新生儿疾病筛查结果分析[J].中国妇幼保健，2017，32（1）：79-81.
[7]	赵正言.新生儿疾病筛查在我国的发展[J].中国儿童保健杂志，2011，19（2）：97-98，101.
[1]	胡亚美，江载芳.诸福棠实用儿科学[M].北京：人民卫生出版社，2003：431-435.
[2]	Centers for Disease Control and Prevention （CDC）.Good la-BoratoryPractices for biochemical genetic testing And new ScreeningForinheritedmetabolicdisorders[J].MMWRRecomm Rep，2012，61（2）：1-44.
[8]	聂星辉，罗洪略，李梅，等.衡阳地区2009年～2014年新生儿疾病筛查回顾与分析[J].中国优生与遗传杂志，2016，24（1）：89，126.
[9]	王川，高倩，尚煜.2011～2016年北京市朝阳区新生儿疾病筛查结果分析[J].中国妇幼保健，2017，32（22）：5653-5655.
[10]	凌秀明.2010年～2014年钦州市新生儿疾病筛查状况及结果分析[J].中国优生与遗传杂志，2016，24（4）：99-100.
[11]	杨青，牟鸿江，汪俊华，等.2013～2016年贵州省新生儿疾病筛查可疑阳性未召回原因[J].职业与健康，2018，34（3）：336-339.
[12]	杨青，牟鸿江，汪俊华.我国新生儿遗传代谢疾病筛查进展[J].中国妇幼卫生杂志，2017，8（4）：1-4.
[13]	张红梅，杨建平.515 947例新生儿疾病筛查结果分析[J].中国妇幼保健，2018，33（17）：3966-3968.
[14]	伍晋辉，李轩，吴怡.新生儿疾病筛查管理中常见问题与对策[J].中西医结合护理（中英文），2017，3（6）：41-43.
[15]	曹小英，黄明珠，蔡宗友，等.新生儿疾病筛查中新生儿疾病筛查网络平台的应用探讨[J].数理医药学杂志，2016，29（4）：532-533.